Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients

Innate immunity is a key component in the pathogenesis of oral mucositis, a universal toxicity of chemoradiation therapy (CRT). Dusquetide, a novel Innate Defense Regulator, has demonstrated both nonclinical and clinical efficacy in ameliorating severe oral mucositis (SOM). Long term follow-up studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudrimoti, Mahesh, Curtis, Amarinthia, Azawi, Samar, Worden, Francis, Katz, Sanford, Adkins, Douglas, Bonomi, Marcelo, Scott, Zack, Elder, Jenna, Sonis, Stephen T., Straube, Richard, Donini, Oreola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470438/
https://www.ncbi.nlm.nih.gov/pubmed/28649557
http://dx.doi.org/10.1016/j.btre.2017.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470438/
https://www.ncbi.nlm.nih.gov/pubmed/28649557
http://dx.doi.org/10.1016/j.btre.2017.05.002

Ejemplares similares